Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Robert Funck
Age : 60
Public asset : 24,256,823 USD
Country of residence : Unknown
Linked companies : Abbott Laboratories

Biography of Robert Funck 
Robert E. Funck occupies the position of Chief Financial Officer & Executive Vice President of Abbott Laboratories. Mr. Funck received an undergraduate degree from Ambrose University.


Current positions of Robert Funck 
Holdings of Robert Funck 
Robert Funck : Personal Network 
Most Read News 
11/20Buffett's Berkshire boosts stakes in Japan's five biggest trading houses
RE
12/01Salesforce shares tumble after surprise exit of co-CEO Taylor
RE
11/23Berkshire Hathaway says Warren Buffett donates shares to family charities
RE
11/30Meta's Zuckerberg says some of Elon Musk's Twitter content approach 'might work'
RE
11/30Juventus has no requirement of additional capital, says Exor's Elkann
RE
11/30Interpol confirms red notice for Angolan billionaire Isabel dos Santos
RE
11/22'Boomerang CEOs' don't always work out; Disney hopes this one bucks trend
RE
11/21Musk says Twitter to hold off relaunching blue check verification
RE
11/19Musk's Twitter poll showing narrow majority want Trump reinstated
RE
11/29Ryanair's O'Leary says industry most optimistic in 25 years
RE
More news


© 2022 People and Ownership :   
Robert Funck : Connections 


Latest news about Robert Funck 
10/19Trending : Abbott Says 3Q Sales Slip, Cites February Infant-Formula Production Shutdown
DJ
10/19Transcript : Abbott Laboratories, Q3 2022 Earnings Call, Oct 19, 2022
CI
07/20Abbott Raises 2022 Outlook on Improved Second-Quarter But Revenue Excluding COVID-19 Test Sales Take Recall Hit
MT
07/20Transcript : Abbott Laboratories, Q2 2022 Earnings Call, Jul 20, 2022
CI
04/20Transcript : Abbott Laboratories, Q1 2022 Earnings Call, Apr 20, 2022
CI
04/20Abbott cuts sales growth forecast on baby formula recall
RE
01/26Abbott Laboratories Fourth-Quarter Results Top Analyst Estimates But Guidance Outlined Below Street Views
MT
More news